Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Express Scripts
Chubb
Teva
Queensland Health
Daiichi Sankyo

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,071,977

« Back to Dashboard

Which drugs does patent 10,071,977 protect, and when does it expire?

Patent 10,071,977 protects HETLIOZ and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 10,071,977
Title:Highly purifid pharmaceutical grade tasimelteon
Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
Inventor(s): Phadke; Deepak (Olathe, KS), Platt; Natalie M (Columbia, MD), Pandrapragada; Ravi K (Clarksburg, MD)
Assignee: VANDA PHARMACEUTICALS INC. (Washington, DC)
Application Number:15/117,734
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,071,977
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 10,071,977
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 10,071,977

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vanda Pharms Inc HETLIOZ tasimelteon CAPSULE;ORAL 205677-001 Jan 31, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Queensland Health
Julphar
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.